Total de visites
| Visites | |
|---|---|
| External ... | 99 |
Total de visites per mes
| de juny 2025 | de juliol 2025 | d’agost 2025 | de setembre 2025 | d’octubre 2025 | de novembre 2025 | de desembre 2025 | |
|---|---|---|---|---|---|---|---|
| External ... | 3 | 1 | 10 | 1 | 2 | 11 | 6 |
Total de descàrregues del fitxer
| Visites | |
|---|---|
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021.pdf | 72 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari6.pdf | 41 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari8.pdf | 20 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari2.pdf | 16 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari1.pdf | 15 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari4.pdf | 14 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari3.pdf | 13 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari7.pdf | 13 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari5.pdf | 10 |
Visites per país
| Visites | |
|---|---|
| Estats Units | 37 |
| Singapur | 18 |
| Xina | 13 |
| Alemanya | 10 |
| Espanya | 7 |
| Âustria | 3 |
| Brasil | 3 |
| Iraq | 2 |
| Bangla Desh | 1 |
| Equador | 1 |
Visites per ciutat
| Visites | |
|---|---|
| Singapore | 14 |
| Beijing | 9 |
| Ashburn | 5 |
| Boydton | 4 |
| Social Circle | 3 |
| Almont | 2 |
| Baghdad | 2 |
| Frankfurt am Main | 2 |
| Los Angeles | 2 |
| Nuremberg | 2 |



